European Opportunities Loom For Value Added Medicines
But Sales Still Lag US, With EU Legislative Review Set To Address Sector’s Need For Reform
• By David Wallace
Panelists discussed opportunities and obstacles for value added medicines at Medicines for Europe’s fifth annual conference • Source: Medicines for Europe
